Correction: An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy

被引：0
|
作者：
Dorothy A. Thompson
Siân E. Handley
Robert H. Henderson
Oliver R. Marmoy
Paul Gissen
机构：
[1] Great Ormond Street Hospital for Children,Clinical and Academic Department of Ophthalmology
[2] UCL Great Ormond Street Institute of Child Health,Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health
[3] University College London,NIHR Great Ormond Street Hospital Biomedical Research Centre
[4] University College London,undefined
来源：
Eye | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2912 / 2912
相关论文
共 50 条
  • [31] STUDIES IN NEURONAL CEROID-LIPOFUSCINOSIS (BATTENS DISEASE)
    MISRA, G
    GARG, HS
    SRIVASTAVA, SK
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 632 - 632
  • [32] LINKAGE ANALYSIS OF NEURONAL CEROID LIPOFUSCINOSIS - REFINED MAPPING OF CLN3 AND EVIDENCE OF LOCUS HETEROGENEITY OF CLN3 AND CLN2
    MITCHISON, HM
    WILLIAMS, RE
    MCKAY, TR
    CALLEN, DF
    THOMPSON, A
    MULLEY, JC
    STALLINGS, RL
    HILDEBRAND, CE
    MOYZIS, RK
    JARVELA, I
    PELTONEN, L
    HAINES, J
    SUTHERLAND, GR
    GARDINER, RM
    CYTOGENETICS AND CELL GENETICS, 1992, 60 (3-4): : 173 - 173
  • [33] A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis
    Yu-Liang Wang
    Zhi-Yong Zeng
    Xing-Wang Song
    Zhuo-Fang Hao
    Yi-Wu Shi
    Bin Tang
    Sheng-Qiang Chen
    Mei-Mei Gao
    Wei Di
    Yue-Sheng Long
    Yong-Hong Yi
    Wei-Ping Liao
    neurogenetics, 2011, 12 : 93 - 95
  • [34] The relationship between the expanded neuronal ceroid lipofuscinosis 2 (CLN2) clinical rating scale for motor function (CLN2 CRS-MX) and GAITRite® parameters
    Hagenah, Luca
    Schwering, Christoph
    Wilson, Catherine
    Wibbeler, Eva
    Westermann, Lena Marie
    Cho, Yoonjin
    Nickel, Miriam
    Schulz, Angela
    Phillips, Dawn
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 55 - 56
  • [35] MOLECULAR MECHANISM OF DISTINCT CLN2 MUTATIONS IN LATE INFANTILE CEROID LIPOFUSCINOSIS
    Steinfeld, R.
    Isbrandt, D.
    Gaertner, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 155 - 155
  • [36] VALPROIC ACID EXTENDS LIFESPAN OF THE ZEBRAFISH MODEL OF CLN2 DISEASE (LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS)
    Mahmood, Fahad
    Zdebik, Anselm
    Au, Alexandra
    Cooke, Jennifer
    Russell, Claire
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [37] Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay
    Ardicli, Didem
    Haliloglu, Goknur
    Gocmen, Rahsan
    Gunbey, Ceren
    Topcu, Meral
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2021, 33 : 94 - 98
  • [38] Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis
    Fietz, Michael
    AlSayed, Moeenaldeen
    Burke, Derek
    Cohen-Pfeffer, Jessica
    Cooper, Jonathan D.
    Dvorakova, Lenka
    Giugliani, Roberto
    Izzo, Emanuela
    Jahnova, Helena
    Lukacs, Zoltan
    Mole, Sara E.
    de Halac, Ines Noher
    Pearce, David A.
    Poupetova, Helena
    Schulz, Angela
    Specchio, Nicola
    Xin, Winnie
    Miller, Nicole
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 160 - 167
  • [39] Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
    Gutic, Medo
    Milosavljevic, Milos N.
    Safiye, Teodora
    Milidrag, Ardea
    Jankovic, Slobodan M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 561 - 570
  • [40] A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis
    Wang, Yu-Liang
    Zeng, Zhi-Yong
    Song, Xing-Wang
    Hao, Zhuo-Fang
    Shi, Yi-Wu
    Tang, Bin
    Chen, Sheng-Qiang
    Gao, Mei-Mei
    Di, Wei
    Long, Yue-Sheng
    Yi, Yong-Hong
    Liao, Wei-Ping
    NEUROGENETICS, 2011, 12 (01) : 93 - 95
12345